DWA
XBIT icon

Dorsey Wright & Associates’s XBiotech XBIT Stock Holding History

Dorsey Wright & Associates’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-518
Closed -$10K – 395
2020
Q3 		$10K Sell
518
-173
-25% -$2.99K ﹤0.01% 200
2020
Q2 		$10K Buy
+691
New +$9.71K ﹤0.01% 263
2019
Q3 		– Sell
-1,050
Closed -$8K – 336
2019
Q2 		$8K Buy
+1,050
New +$9.13K ﹤0.01% 279

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dorsey Wright & Associates's XBIT Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of XBiotech (XBIT) in Q4 2020, closing a stake of 518 shares — an estimated $10K sold.

Dorsey Wright & Associates first reported a position in XBIT in Q2 2019 and held it in 3 quarters. The position peaked at $10K in Q3 2020. 66 funds tracked by Wall St. Rank hold XBIT as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining XBiotech position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 518 XBiotech shares in Q4 2020, an estimated $10K.
  • Dorsey Wright & Associates first reported a position in XBiotech in Q2 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's XBiotech position peaked at $10K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held XBiotech as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.